Compare BOTJ & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOTJ | ATRA |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | 10 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 94.2M |
| IPO Year | 2015 | 2014 |
| Metric | BOTJ | ATRA |
|---|---|---|
| Price | $27.47 | $9.38 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 31.4K | ★ 50.8K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | 13.71 | ★ 122.52 |
| EPS | ★ 1.32 | N/A |
| Revenue | $4,273,000.00 | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.10 | ★ N/A |
| Revenue Growth | ★ 6.74 | N/A |
| 52 Week Low | $14.44 | $3.92 |
| 52 Week High | $28.56 | $19.15 |
| Indicator | BOTJ | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 54.82 |
| Support Level | $26.27 | $8.98 |
| Resistance Level | $28.42 | $10.02 |
| Average True Range (ATR) | 0.56 | 0.53 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 88.54 | 34.39 |
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.